DSS Pharmaceutical Private Limited
About DSS Pharmaceutical Private Limited
Data last updated:
DSS Pharmaceutical Private Limited is a private limited company based in Pune, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 04 September 2017 and has been in existence for over 9 years.
The company is registered with the Registrar of Companies (ROC), Pune, under CIN U51909PN2017PTC172345. Its GSTIN is 27AAGCD3376D1ZQ (Maharashtra).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Ashish Vishnupant Padmane and Arun Namdev Dahifale.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Fl – A – 205 Induban Residency Sr No.222/5A Nr Gangotri, Pune, Maharashtra, India – 411039.
As per the financials filed for FY 2025, the company reported a revenue of ₹70.72 Lakh, a growth of 13% compared to the previous year. For the same year it recorded a net profit of ₹2.16 Lakh (net margin 3.1%) and EBITDA of ₹2.46 Lakh (EBITDA margin 3.5%). Revenue has grown at a compounded annual rate (CAGR) of 7% over three years and 6% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressFl – A – 205 Induban Residency Sr No.222/5A Nr Gangotri, Pune, Maharashtra, India – 411039
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of DSS Pharmaceutical Private Limited
The main business activity of DSS Pharmaceutical is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Board of Directors of DSS Pharmaceutical Private Limited
DSS Pharmaceutical has 4 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Arun Namdev Dahifale Also directs: Analyte Pharmaceuiticals Private Limited | Additional Director | 10 Apr 2018 | 8 Years 5 Months | Current |
| Ashish Vishnupant Padmane Also directs: DSS Lifetech Private Limited | Director | 04 Sep 2017 | 9 Years 1 Months | Current |
| Vinod Baliram Yadav | Additional Director | 14 Dec 2017 | 8 Years 9 Months | Current |
| Sandesh Anil Raskar | Additional Director | 14 Dec 2017 | 8 Years 9 Months | Current |
Financials of DSS Pharmaceutical Private Limited FY 2025 filings available
DSS Pharmaceutical Private Limited reported revenue of ₹70.72 Lakh (up 13% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of DSS Pharmaceutical Private Limited
Revenue has grown at a compounded annual rate (CAGR) of 6% over five years, including 13% growth in the latest year. EBITDA rose 8% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of DSS Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹2.46 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹2.16 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of DSS Pharmaceutical Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.5% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 3.1% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of DSS Pharmaceutical are in the company report.
Financial statements from FY 2018
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of DSS Pharmaceutical Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of DSS Pharmaceutical Private Limited
DSS Pharmaceutical Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at DSS Pharmaceutical Private Limited
Employment history and EPFO contributions of people linked to DSS Pharmaceutical.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of DSS Pharmaceutical Private Limited
DSS Pharmaceutical has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27AAGCD3376D1ZQ | Maharashtra | Active | 16 Oct 2017 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for DSS Pharmaceutical Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by DSS Pharmaceutical Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of DSS Pharmaceutical Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of DSS Pharmaceutical Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on DSS Pharmaceutical Private Limited
Frequently Asked Questions about DSS Pharmaceutical Private Limited
DSS Pharmaceutical is an active private limited company based in Pune, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 04 September 2017 (9+ years old) and is registered under CIN U51909PN2017PTC172345.
DSS Pharmaceutical reported revenue of ₹70.72 Lakh for FY 2025 (up 13% YoY).
DSS Pharmaceutical has 4 current directors:
- Arun Namdev Dahifale - Additional Director
- Ashish Vishnupant Padmane - Director
- Vinod Baliram Yadav - Additional Director
- Sandesh Anil Raskar - Additional Director
DSS Pharmaceutical reported a net profit of ₹2.16 Lakh (net margin 3.1%) and EBITDA of ₹2.46 Lakh (EBITDA margin 3.5%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of DSS Pharmaceutical is 7% over three years and 6% over five years. In the latest year (FY 2025) revenue rose 13%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of DSS Pharmaceutical is 27AAGCD3376D1ZQ, registered in Maharashtra.
The CIN (Corporate Identification Number) of DSS Pharmaceutical is U51909PN2017PTC172345. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
DSS Pharmaceutical was incorporated on 04 September 2017, making it 9+ years old. It is registered with the Registrar of Companies, Pune.
The registered office of DSS Pharmaceutical is at Fl – A – 205 Induban Residency Sr No.2225A Nr Gangotri, Pune, Maharashtra, India – 411039.